Hodgkins Lymphoma Clinical Trial
Official title:
Randomisierte Phase II Studie Zum Einsatz Von Goserelin Und Oralen Kontrazeptiva Zur Reduktion Ovarieller Toxizitäten während Zytostatischer Primärtherapie Bei Fertilen Patientinnen Mit Hodgkin Lymphom in Fortgeschrittenen Stadien
This study is designed to test the the protective capacity of Goserelin compared with oral contraceptive
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00383097 -
Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma
|
Phase 1 | |
| Completed |
NCT01517581 -
Brown Fat Activity and White Fat Accumulation
|
N/A | |
| Completed |
NCT00515554 -
HD18 for Advanced Stages in Hodgkins Lymphoma
|
Phase 3 | |
| Terminated |
NCT01326728 -
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
|
||
| Completed |
NCT00837200 -
Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies
|
Phase 2 | |
| Terminated |
NCT02603419 -
Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)
|
Phase 1 | |
| Active, not recruiting |
NCT02099266 -
Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment
|
N/A | |
| Completed |
NCT02057445 -
3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma
|
Phase 1 | |
| Terminated |
NCT01636388 -
Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma
|
Phase 2 | |
| Terminated |
NCT01300611 -
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
|
Phase 1 | |
| Enrolling by invitation |
NCT00923442 -
Biology Studies of Hematologic Cancers
|
||
| Terminated |
NCT00973804 -
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
|
Phase 1 | |
| Completed |
NCT00739141 -
Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
|
Phase 2 | |
| Recruiting |
NCT05134740 -
(TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL).
|
Phase 1 | |
| Completed |
NCT01572662 -
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
|
Phase 2 |